Vertos Medical

Vertos Medical, acquired by Stryker, is a leader in interventional spine, developing minimally invasive devices to treat debilitating back pain from conditions like spinal stenosis and vertebral fractures. Its strategy centers on leveraging two core technology platforms—precision vertebral access and radiofrequency ablation—to create outpatient procedures with compelling clinical and economic outcomes. Key achievements include establishing the mild procedure as a standard of care for ligamentous stenosis and launching the next-generation OptaBlate system for nerve ablation, all supported by Stryker's vast commercial and educational infrastructure.

A platform combining precision vertebral access and controlled radiofrequency ablation (RFA) to enable minimally invasive, image-guided procedures for spinal decompression, nerve ablation, and tumor treatment.

Faces competition across its portfolio: in LSS from surgical implants and injections; in BVNA from Relievant/Boston Scientific's Intracept; in vertebral augmentation from Medtronic, Globus, and J&J. Stryker's integrated portfolio offering and commercial scale are primary competitive advantages.